Ventureast Invests $4 mn in Series C funding in DiabetOmics, Medical Diagnostics Company

Ventureast has led a $4 mn investment in Diabetomics, a growth-stage medical diagnostics company.diabetomics-logo
DiabetOmics claims to be the world’s first company to develop a patented non-invasive, saliva-based glucose monitoring test for diabetes patients and an early detection test for gestational diabetes (in pregnant women) and pre-eclampsia (high blood pressure in pregnant women).
The investment will be used to advance product development, obtain regulatory approvals in EU, USA and in emerging markets, set up manufacturing facility in India and begin commercialization. The Company plans to obtain CE Mark in the second half of 2015 and commence commercialization in India and several other countries in early 2016.

Add comment

NextBigWhat brings you curated insights and wisdom on product and growth from the wild web.

Over 2 million people receive our weekly curated insights.

Newsletter

Newsletter